"At $70-80m free cash/assets (after payables) you're paying roughly 10x for what seems to be trough earnings. "
That's the correct - but very much understated - take, I think.
If one excludes the P&L volatility from Investment Gains/Losses (which have been greatly reduced since the OZG/WIZ sale in 2020), EZL has never made less than $15m in Pre-Tax Profit over any 12-month period (that low happened in the 12-m to June 2023), as can be seen in the chart:
On average, EZL's PBT over any 12-month period has been $25m, and the peak is in excess of $35m.
Taxing those trough, average and peak PBT numbers at 30%, yields Raw P/E multiples of 13.7x (based on trough earnings), 8.2x based on mid-cycle average and 5.9x on a peak scenario:
Adjusting for the $65m net cash balance (cash-at-bank less net broker payables), gives valuations that are half the level of the raw multiples.
Feels very much like one of those rare situations of:
Heads: I win a lot.
Tails: I don't lose much at all.
.
- Forums
- ASX - By Stock
- EZL
- Ann: Appendix 4E and Full Year Statutory Accounts
Ann: Appendix 4E and Full Year Statutory Accounts, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EZL (ASX) to my watchlist
(20min delay)
|
|||||
Last
85.0¢ |
Change
0.005(0.59%) |
Mkt cap ! $140.0M |
Open | High | Low | Value | Volume |
84.5¢ | 86.0¢ | 84.5¢ | $121.2K | 142.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14812 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14812 | 0.845 |
1 | 5000 | 0.840 |
1 | 13383 | 0.830 |
1 | 10000 | 0.825 |
2 | 9758 | 0.820 |
Price($) | Vol. | No. |
---|---|---|
0.850 | 15000 | 1 |
0.865 | 2153 | 1 |
0.870 | 9597 | 2 |
0.875 | 23816 | 2 |
0.880 | 20272 | 1 |
Last trade - 12.10pm 13/11/2024 (20 minute delay) ? |
Featured News
EZL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online